Lv2
160 积分 2020-08-18 加入
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
1个月前
已完结
Joint MR-PET Reconstruction Using a Multi-Channel Image Regularizer
3个月前
已完结
Development of an Optimized CXCR4-Targeting Theranostic Pair
3个月前
已完结
[68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques
4个月前
已完结
Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study
4个月前
已完结
Chemokine Receptor 4–Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma
4个月前
已完结
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-RHPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
4个月前
已完结
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
4个月前
已完结
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
4个月前
已完结
Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China
4个月前
已完结
皖公网安备34019202002308
